Table 1 Demographic and clinical characteristics of women in the UKWCS by fifth of intake of acrylamide

From: Dietary acrylamide intake and risk of breast cancer in the UK women's cohort

 

Acrylamide intake

Fifth

1

2

3

4

5

Mean ( μ g day−1)

6

11

15

20

32

Range ( μ g day−1)

0–9

9–13

13–17

17–23

23–150

Mean age (years) (s.d.)

52.8 (9.2)

52.7 (9.1)

52.5 (9.3)

51.6 (9.3)

51.4 (9.5)

Mean BMI (kg m−2) (s.d.)

24.0 (4.2)

24.5 (4.4)

24.4 (4.1)

24.6 (4.6)

24.8 (4.5)

Mean physical activity (hours per day) (s.d.)

0.3 (0.5)

0.3 (0.5)

0.3 (0.5)

0.2 (0.4)

0.2 (0.5)

Mean age at menarche (years) (s.d.)

12.8 (1.7)

12.8 (1.6)

12.8 (1.6)

12.8 (1.6)

12.9 (1.6)

Current HRT use (%)

1336 (20%)

1386 (21%)

1348 (20%)

1239 (19%)

1206 (18%)

Current OCP use (%)

251 (4%)

232 (3%)

278 (4%)

264 (4%)

266 (4%)

Nulliparous (%)

1954 (29%)

1614 (24%)

1394 (21%)

1346 (20%)

1240 (18%)

Postmenopause (%)

3776 (56%)

3716 (55%)

3620 (54%)

3360 (50%)

3300 (49%)

Incident breast cancer (%)

220 (3%)

213 (3%)

219 (3%)

211 (3%)

218 (3%)

Mean total energy intake (MJ) (s.d.)

8.0 (2.4)

8.9 (2.4)

9.6 (2.4)

10.4 (2.6)

12.1 (3.3)

Mean ethanol intake (g day−1) (s.d.)

9.0 (11.4)

9.1 (10.5)

8.7 (10.6)

8.5 (10.1)

8.0 (10.1)

Current smoker (%)

684 (11%)

682 (10%)

710 (11%)

718 (11%)

846 (13%)

No education >14 years (%)

840 (14%)

951 (15%)

1038 (17%)

1076 (17%)

1291 (21%)

  1. Abbreviations: BMI=body mass index; HRT=hormone replacement therapy; OCP=oral contraceptive pill; UKWCS=UK Women's Cohort Study.